Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-07 · accession 0001209191-23-036051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-09 | 2023-06-07 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $17.04 | -8,897 | 382.7K | -2% | -$151.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-07 | S | D | 6,106 | $17.04 | 376,602 | D | — | — | (F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. |
| 2 | Common | Common Stock | 2023-06-07 | S | D | 2,791 | $17.04 | 382,708 | D | — | — | (F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. (F2) Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan. |